1. |
Sapey E, Stockley RA. COPD exacerbations: 2. Aetiology. Thorax,2006, 61: 250-258 .
|
2. |
Sidney S, Sorel M, Quesenberry CP Jr, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest, 2005 , 128: 2068-2075.
|
3. |
Carson JL, Terrin ML, Duff A, et al. Pulmonary embolism and mortality in patients with COPD. Chest, 1996, 110: 1212-1219.
|
4. |
Tillie-Leblond I,Marquette CH, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med,2006, 144: 390-396.
|
5. |
Erelel M, Cuhadaroglu C, Ece T, et al. The frequency of deep venous thrombosis and pulmonary embolus in acute exacerbation of chronic obstructive pulmonary disease. Respir Med, 2002 , 96: 515 -518.
|
6. |
Shetty R, Seddighzadeh A, Piazza G, et al. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis, 2008, 26 : 35-40.
|
7. |
Rutschmann OT, Cornuz J, Poletti PA, et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax, 2007, 62 : 121-125 .
|
8. |
Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and meta analysis. Chest, 2009, 135: 786 -793.
|
9. |
Lippmann M, Fein A. Pulmonary embolism in the patient with chronic obstructive pulmonary disease. A diagnostic dilemma.Chest, 1981, 79: 39-42.
|
10. |
Wagner PD, Dantzker DR, Dueck R, et al. Ventilationperfusion inequality in chronic obstructive pulmonary disease. J Clin Invest,1977, 59: 203-216 .
|
11. |
Hartmann IJ, Hagen PJ, Melissant CF, et al. Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/ perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism. Am J Respir Crit Care Med, 2000, 162 : 2232-2237.
|
12. |
Ambrosetti M, Ageno W, Spanevello A, et al. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Thromb Res, 2003 , 112: 203-207.
|
13. |
Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD.The association of non-university affiliated intensive care specialist physicians of france. Am J Respir Crit Care Med, 2000, 161: 1109 -1114.
|
14. |
Kahn SR, Panju A, GeertsW, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res, 2007, 119 : 145-155.
|
15. |
Alikhan R, Cohen AT. A safety analysis of thromboprophylaxis in acute medical illness. Thromb Haemost, 2003 , 89: 590-591.
|
16. |
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: american college of chest physicians evidencebased clinical practice guidelines ( 8th Edition) . Chest, 2008, 133 :381S-453S.
|